Australia markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2949+0.0199 (+7.24%)
At close: 04:00PM EDT
0.3000 +0.01 (+1.73%)
After hours: 06:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.73M
Enterprise value -6.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.23
Price/book (mrq)0.14
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.20%
S&P500 52-week change 326.36%
52-week high 32.0800
52-week low 30.2280
50-day moving average 30.3146
200-day moving average 30.4950

Share statistics

Avg vol (3-month) 3399.1k
Avg vol (10-day) 3133.13k
Shares outstanding 56.06M
Implied shares outstanding 66.35M
Float 86.68M
% held by insiders 10.99%
% held by institutions 18.21%
Shares short (30 Apr 2024) 4359k
Short ratio (30 Apr 2024) 40.48
Short % of float (30 Apr 2024) 45.93%
Short % of shares outstanding (30 Apr 2024) 45.93%
Shares short (prior month 28 Mar 2024) 410.34k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 July 2020
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 307 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -108.01%
Operating margin (ttm)-153.18%

Management effectiveness

Return on assets (ttm)-29.56%
Return on equity (ttm)-51.73%

Income statement

Revenue (ttm)5.63M
Revenue per share (ttm)0.93
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA -6.42M
Net income avi to common (ttm)-6.08M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.64M
Total cash per share (mrq)0.92
Total debt (mrq)1.07M
Total debt/equity (mrq)9.64%
Current ratio (mrq)6.58
Book value per share (mrq)1.75

Cash flow statement

Operating cash flow (ttm)-6.61M
Levered free cash flow (ttm)-4.2M